甲状腺がん診断の世界市場

甲状腺がん診断の世界市場は2030年までに67億米ドルに達する見込み

2024年に53億米ドルと推定される甲状腺がん診断の世界市場は、2024年から2030年にかけてCAGR 3.7%で成長し、2030年には67億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである器具は、CAGR 3.0％を記録し、分析期間終了時には40億米ドルに達すると予測されます。消耗品＆アクセサリー分野の成長率は、分析期間中CAGR 4.9％と推定されます。

米国市場は15億米ドル、中国はCAGR6.8％で成長予測

米国の甲状腺がん診断市場は、2024年に15億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の「甲状腺がん診断」市場- 主要動向と促進要因のまとめ

プレシジョン・オンコロジーの時代に甲状腺がん診断はどのように進化しているか？

甲状腺がん診断を取り巻く環境は、分子生物学、画像技術、個別化医療の進歩に牽引され、大きな変革期を迎えています。歴史的に触診、超音波、細針吸引（FNA）に依存してきた甲状腺がんの検出は、現在ではゲノム・プロファイリング、バイオマーカー解析、高解像度画像診断によってますますサポートされるようになっています。これらのツールは診断精度を高め、不必要な手術を減らし、甲状腺乳頭がんや濾胞がんなどの悪性腫瘍の早期発見を可能にしています。BRAF、RAS、RET、TERTなどの遺伝子の変異を特定するための次世代シーケンサー（NGS）パネルの使用は、特に細胞診が不確定な症例において、臨床医が結節を良性か悪性かを区別する方法に革命をもたらしています。ラジオミクスとAIに基づく超音波データの解釈もまた、従来の画像診断の予測価値を向上させ、より確信に満ちた臨床的意思決定を可能にしています。リキッドバイオプシーは、まだ始まったばかりではあるが、非侵襲的で繰り返し可能な病気の進行と再発のモニタリングの可能性を秘めています。このような技術革新は診断精度を高めるだけでなく、標的治療や個別化治療計画への幅広い動向を支えています。

甲状腺がん罹患率の上昇は世界の診断の優先順位を変えるか？

甲状腺がんの世界の罹患率は、画像診断の普及と認知度の向上もあって、特にヘルスケアシステムの進んだ地域で着実に増加しています。この疫学的動向は、公衆衛生システムや臨床診療所に対して、甲状腺結節の早期発見と鑑別を優先するよう促しています。甲状腺結節の増加の多くは、小さくて低悪性度の腫瘍の発見によるものであるが、過剰診断や過剰治療に対する懸念が、より微妙な診断枠組みへのシフトに拍車をかけています。新たなガイドラインでは、画像診断、細胞診、分子検査を組み合わせて患者管理を調整するリスク層別化診断アプローチを提唱しています。アジア、特に韓国と中国では、患者数の増加により、全国的なスクリーニングへの取り組みと診断インフラへの投資が増加しています。一方、アフリカやラテンアメリカの一部では、ヘルスケアに対する認識やアクセスが向上するにつれて、診断ツールに対する需要が遅れながらも高まっています。このような世界のシフトは、診断ワークフローを再構築し、費用対効果に優れ、拡張性があり、低侵襲な技術への需要を強めています。

どのような診断技術が甲状腺がん検出の新たな標準となっているのか？

甲状腺がんの診断手段は、画像診断、細胞病理、分子診断にまたがる革新的技術によって急速に拡大しています。高周波超音波検査は依然として初期評価の要であるが、その診断精度は、エラストグラフィ、ドップラー流解析、結節の形態や血管を解析する機械学習アルゴリズムによって著しく向上しています。細胞学的評価のゴールドスタンダードである細針吸引生検は、遺伝子変異や発現プロファイルのパネルを評価する分子検査プラットフォームで補完されつつあります。ThyroSeq、Afirma、RosettaGXのような市販のアッセイは、不確定結節の悪性リスクを知る貴重な洞察を提供し、手術が正当化されるかどうかの指針となります。SPECT/CTやPET/CT画像は、特に高リスク症例や転移症例において、病期分類、再発モニタリング、治療反応性評価において役割が高まっています。AIによる病理検査プラットフォームは、細胞診判読の一貫性を向上させ、観察者間のばらつきを減少させています。最先端では、血液中の循環腫瘍DNA（ctDNA）とマイクロRNAシグネチャーの調査が、非侵襲的サーベイランスの新たなレイヤーを追加することを約束しています。これらの技術革新により、甲状腺がん診断は正確性、効率性、個別化によって定義される未来へと向かっています。

甲状腺がん診断市場の成長にはいくつかの要因があります。

甲状腺がん診断市場の堅調な成長は、技術的、人口統計的、ヘルスケア政策的な要因によって後押しされています。甲状腺結節の世界の増加-その多くは高度な診断技術による鑑別を必要とする-は主要な臨床促進要因です。超音波検査やCT検査のような高解像度画像診断技術の使用増加により、より多くの偶発的な甲状腺結節が発見され、その多くが診断のために紹介されています。日常臨床における分子診断とゲノムプロファイリングの利用可能性の拡大により、不確定症例のより正確な評価が可能になり、それにより診断の不確実性が減少し、患者の管理経路が改善されています。さらに、甲状腺結節の評価におけるリスクベースの個別化アプローチへの臨床ガイドラインのシフトが、病院や診断ラボに統合診断プラットフォームへの投資を促しています。非侵襲的で正確な診断に対する患者の需要も、リキッドバイオプシーや高度な画像診断ツールの採用に影響を与えています。人口の高齢化、新興国におけるヘルスケアアクセスの向上、内分泌がんに対する意識の高まりは、診断件数をさらに押し上げています。さらに、バリューベース・ケアとアウトカム最適化の傾向は、医療提供者に不要な処置を減らし診断精度を向上させる技術の採用を促し、先進的な甲状腺がん診断の市場モメンタムを強めています。

セグメント

製品タイプ（装置、消耗品、アクセサリ）;検査タイプ（画像検査、生検、血液検査、その他の検査タイプ）;エンドユーザー（病院、提携研究所、独立診断研究所、画像診断センター、がん研究機関、その他のエンドユーザー）

調査対象企業の例（注目の32社）

• Abbott Laboratories
• Agilent Technologies Inc.
• Bayer AG
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Canon Inc.
• Cepheid
• DiaSorin S.p.A.
• Eli Lilly and Company
• FUJIFILM Holdings Corporation
• GE HealthCare
• Hologic Inc.
• Illumina Inc.
• Koninklijke Philips N.V.
• Labcorp
• Merck KGaA
• Myriad Genetics Inc.
• QIAGEN N.V.
• Quest Diagnostics Inc.
• Siemens Healthineers

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Thyroid Cancer Diagnostics Market to Reach US$6.7 Billion by 2030

The global market for Thyroid Cancer Diagnostics estimated at US$5.3 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Consumables & Accessories segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 6.8% CAGR

The Thyroid Cancer Diagnostics market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global "Thyroid Cancer Diagnostics" Market - Key Trends & Drivers Summarized

How Is Thyroid Cancer Diagnostics Evolving in the Age of Precision Oncology?

The landscape of thyroid cancer diagnostics is undergoing a significant transformation, driven by advancements in molecular biology, imaging technologies, and personalized medicine. Historically reliant on palpation, ultrasound, and fine-needle aspiration (FNA), thyroid cancer detection is now increasingly supported by genomic profiling, biomarker analysis, and high-resolution imaging. These tools are enhancing diagnostic accuracy, reducing unnecessary surgeries, and enabling earlier detection of malignancies such as papillary and follicular thyroid carcinomas. The use of next-generation sequencing (NGS) panels for identifying mutations in genes like BRAF, RAS, RET, and TERT is revolutionizing how clinicians distinguish between benign and malignant nodules, particularly in cases with indeterminate cytology. Radiomics and AI-based interpretation of ultrasound data are also improving the predictive value of traditional imaging, allowing for more confident clinical decision-making. Liquid biopsies, though still emerging, hold potential for non-invasive, repeatable monitoring of disease progression and recurrence. These technological innovations are not only enhancing diagnostic precision but also supporting the broader trend toward targeted therapies and individualized treatment planning.

Are Rising Thyroid Cancer Rates Changing the Global Diagnostic Priorities?

The global incidence of thyroid cancer has been steadily increasing, particularly in regions with advanced healthcare systems, due in part to widespread use of imaging and increased awareness. This epidemiological trend is prompting public health systems and clinical practices to prioritize the early detection and differentiation of thyroid nodules, many of which are asymptomatic and discovered incidentally during unrelated imaging exams. While much of the increase is attributed to the detection of small, indolent tumors, concerns over overdiagnosis and overtreatment are fueling a shift toward more nuanced diagnostic frameworks. Emerging guidelines advocate for risk-stratified diagnostic approaches that combine imaging features, cytology, and molecular testing to tailor patient management. In Asia, particularly South Korea and China, rising case numbers have led to national screening efforts and increased investment in diagnostic infrastructure. Meanwhile, underserved regions in Africa and parts of Latin America are seeing a delayed but growing demand for diagnostic tools as awareness and access to healthcare improve. These global shifts are reshaping diagnostic workflows and intensifying demand for cost-effective, scalable, and minimally invasive technologies.

What Diagnostic Technologies Are Setting New Standards in Thyroid Cancer Detection?

The diagnostic arsenal for thyroid cancer is expanding rapidly, with innovations that span imaging, cytopathology, and molecular diagnostics. High-frequency ultrasonography remains the cornerstone of initial evaluation, but its diagnostic accuracy is now being significantly enhanced by elastography, Doppler flow analysis, and machine learning algorithms that analyze nodule morphology and vascularity. Fine-needle aspiration biopsy, the gold standard for cytological evaluation, is being supplemented with molecular testing platforms that evaluate panels of gene mutations and expression profiles. Commercial assays such as ThyroSeq, Afirma, and RosettaGX offer valuable insights into the malignancy risk of indeterminate nodules, guiding whether surgery is warranted. SPECT/CT and PET/CT imaging are playing a growing role in staging, recurrence monitoring, and therapy response assessment, particularly in high-risk or metastatic cases. AI-assisted pathology platforms are improving the consistency of cytology interpretation, reducing inter-observer variability. At the frontier, research into circulating tumor DNA (ctDNA) and microRNA signatures in blood promises to add a new layer of non-invasive surveillance. Together, these innovations are moving thyroid cancer diagnostics toward a future defined by accuracy, efficiency, and personalization.

The Growth in the Thyroid Cancer Diagnostics Market Is Driven by Several Factors…

The robust growth in the thyroid cancer diagnostics market is being fueled by a blend of technological, demographic, and healthcare policy-related factors. Rising global incidence of thyroid nodules-many requiring differentiation through advanced diagnostic techniques-is a key clinical driver. Increased use of high-resolution imaging technologies, such as ultrasound and CT scans, is uncovering a larger number of incidental thyroid nodules, many of which are being referred for diagnostic workup. The expanding availability of molecular diagnostics and genomic profiling in routine clinical practice is enabling more precise evaluation of indeterminate cases, thereby reducing diagnostic uncertainty and improving patient management pathways. Moreover, shifting clinical guidelines toward risk-based, personalized approaches to thyroid nodule evaluation are pushing hospitals and diagnostic labs to invest in integrated diagnostic platforms. Patient demand for non-invasive and accurate diagnostics is also influencing the adoption of liquid biopsy and advanced imaging tools. Aging populations, rising healthcare access in emerging economies, and growing awareness about endocrine cancers are further boosting diagnostic volumes. Additionally, the trend toward value-based care and outcome optimization is encouraging providers to adopt technologies that reduce unnecessary procedures and improve diagnostic accuracy, reinforcing the market momentum for advanced thyroid cancer diagnostics.

SCOPE OF STUDY:

The report analyzes the Thyroid Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Instruments, Consumables & Accessories); Test Type (Imaging Test, Biopsy, Blood Test, Other Test Types); End-Use (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• Agilent Technologies Inc.
• Bayer AG
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Canon Inc.
• Cepheid
• DiaSorin S.p.A.
• Eli Lilly and Company
• FUJIFILM Holdings Corporation
• GE HealthCare
• Hologic Inc.
• Illumina Inc.
• Koninklijke Philips N.V.
• Labcorp
• Merck KGaA
• Myriad Genetics Inc.
• QIAGEN N.V.
• Quest Diagnostics Inc.
• Siemens Healthineers

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Thyroid Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Thyroid Cancer Drives Diagnostic Demand
  • Growing Preference for Non-Invasive Biopsy Techniques Spurs Market Growth
  • Advances in Molecular and Genetic Testing Strengthen Diagnostic Accuracy
  • Expansion of Personalized Treatment Protocols Throws Spotlight on Early Diagnosis
  • AI Integration in Radiology and Ultrasound Accelerates Screening Capabilities
  • Increased Awareness Campaigns Enhance Early Detection Rates
  • Rise in Female Patient Population Expands Addressable Market
  • Innovation in Fine Needle Aspiration Biopsy Tools Drives Market Acceptance
  • Demand for Companion Diagnostics with Targeted Therapies Enhances Adoption
  • Hospital and Diagnostic Lab Expansion in Emerging Markets Sustains Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Thyroid Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Thyroid Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Consumables & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cancer Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cancer Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Associated Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Associated Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Associated Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Independent Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Independent Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Independent Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Imaging Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Imaging Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Imaging Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Blood Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• JAPAN
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• CHINA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• EUROPE
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Thyroid Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• FRANCE
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• GERMANY
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• INDIA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Thyroid Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030
• AFRICA
  • Thyroid Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Thyroid Cancer Diagnostics by Product Type - Instruments and Consumables & Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments and Consumables & Accessories for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Thyroid Cancer Diagnostics by End-Use - Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Uses, Hospitals, Associated Labs and Independent Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Thyroid Cancer Diagnostics by Test Type - Imaging Test, Biopsy, Blood Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Thyroid Cancer Diagnostics by Test Type - Percentage Breakdown of Value Sales for Imaging Test, Biopsy, Blood Test and Other Test Types for the Years 2015, 2025 & 2030

IV. COMPETITION